Bellicum Pharmaceuticals, Inc., a clinical stage biopharma company developing novel cellular immunotherapies, has entered into a lease agreement to enable in-house cell therapy manufacturing to supply clinical trials. The additional 27,000 sq.-ft. will be located at the company’s current headquarters adjacent to the Texas Medical Center in Houston.   “Bringing manufacturing in-house allows us to build upon our process and assay development expertise and streamline the production of our cell ther...